Pharmacytimes http://www.pharmacytimes.com/rss PharmacyTimes.com offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Wed, 29 Mar 17 07:11:23 +0000 Wed, 29 Mar 17 07:11:23 +0000 Pharmacy Owners Charged in $158 Million Health Care Fraud Scheme http://www.pharmacytimes.com/news/pharmacy-owners-charged-in-158-million-health-care-fraud-scheme http://www.pharmacytimes.com/news/pharmacy-owners-charged-in-158-million-health-care-fraud-scheme Eight individuals from Texas have been charged for their participation in a health care fraud scheme involving at least 3 pharmacies and $158 million in false claims for costly compound medications, according to the Department of Justice (DOJ).&nbsp;<br /> &nbsp; Tue, 28 Mar 17 16:26:08 +0000 FDA Approves Treatment for Moderate-to-Severe Atopic Dermatitis http://www.pharmacytimes.com/product-news/fda-approves-treatment-for-moderatetosevere-atopic-dermatitis http://www.pharmacytimes.com/product-news/fda-approves-treatment-for-moderatetosevere-atopic-dermatitis The FDA has approved Dupixent (dupilumab) injection, from Sanofi and Regeneron Pharmaceuticals, for the treatment of adults with inadequately controlled moderate-to-severe atopic dermatitis (AD).&nbsp; Tue, 28 Mar 17 16:17:25 +0000 FDA Approves Zejula for Maintenance Treatment of Cancer http://www.pharmacytimes.com/product-news/fda-approves-zejula-for-maintenance-treatment-of-cancer http://www.pharmacytimes.com/product-news/fda-approves-zejula-for-maintenance-treatment-of-cancer The FDA has approved Tesaro&rsquo;s Zejula (niraparib) for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.&nbsp; Mon, 27 Mar 17 21:27:41 +0000 Dr Seth J. Baum on the Patient's Role in Getting PCSK9 Inhibitors Approved by Payers http://www.pharmacytimes.com/news/dr-seth-j-baum-on-the-patients-role-in-getting-pcsk9-inhibitors-approved-by-payers http://www.pharmacytimes.com/news/dr-seth-j-baum-on-the-patients-role-in-getting-pcsk9-inhibitors-approved-by-payers It remains unclear why insurers approve some patients for PCSK9 inhibitors while denying others with similar clinical characteristics, according to Seth J. Baum, MD, FACC, FACPM, FAHA, FNLA, FASPC, president of the American Society for Preventive Cardiology, who presented an abstract on the subject at the American College of Cardiology 66th Scientific Session.&nbsp; Sat, 25 Mar 17 21:08:05 +0000 AHCA Withdrawn Prior to Vote http://www.pharmacytimes.com/news/ahca-withdrawn-prior-to-vote http://www.pharmacytimes.com/news/ahca-withdrawn-prior-to-vote Failing to secure sufficient support for their proposed Affordable Care Act (ACA) replacement, Republicans leaders have pulled the American Health Care Act&nbsp;(AHCA) from the House floor, cancelling a scheduled vote on the health care legislation<br /> &nbsp; Fri, 24 Mar 17 21:01:20 +0000 FDA Grants Accelerated Approval to First Treatment for Rare Skin Cancer http://www.pharmacytimes.com/product-news/fda-grants-accelerated-approval-to-first-treatment-for-rare-skin-cancer http://www.pharmacytimes.com/product-news/fda-grants-accelerated-approval-to-first-treatment-for-rare-skin-cancer The FDA granted accelerated approval to the first treatment for metastatic Merkel cell carcinoma (MCC).&nbsp; Thu, 23 Mar 17 19:33:53 +0000 How Does Social Media Impact Pharmacy Practice? http://www.pharmacytimes.com/news/how-does-social-media-impact-pharmacy-practice http://www.pharmacytimes.com/news/how-does-social-media-impact-pharmacy-practice Everybody seems to use social media, and pharmacists are no exception. However, it&#39;s been unclear how pharmacists employ social media in their daily professional practice. Thu, 23 Mar 17 14:59:53 +0000 Verdict Reached for NECC Pharmacist in Meningitis Outbreak Trial http://www.pharmacytimes.com/news/verdict-reached-for-necc-pharmacist-in-meningitis-outbreak-trial http://www.pharmacytimes.com/news/verdict-reached-for-necc-pharmacist-in-meningitis-outbreak-trial The meningitis outbreak trial&nbsp;involving the New England Compounding Center&nbsp;(NECC) pharmacist Barry Cadden has reached a final verdict.&nbsp; Wed, 22 Mar 17 16:03:20 +0000 Breast Cancer Drug Combo Improved Progression-Free Survival in Phase 3 Study http://www.pharmacytimes.com/product-news/breast-cancer-drug-combo-improved-progressionfree-survival-in-phase-3-study http://www.pharmacytimes.com/product-news/breast-cancer-drug-combo-improved-progressionfree-survival-in-phase-3-study Eli Lilly and Company recently announced positive late-stage results in its clinical trial testing a combination of its experimental breast cancer drug and another widely-used treatment.&nbsp; Wed, 22 Mar 17 13:52:20 +0000 FDA Approves Add-On Drug for Parkinson's Disease http://www.pharmacytimes.com/product-news/fda-approves-addon-drug-for-parkinsons-disease http://www.pharmacytimes.com/product-news/fda-approves-addon-drug-for-parkinsons-disease The FDA has approved Newron Pharmaceutical&rsquo;s Xadago (safinamide), an add-on treatment for patients with Parkinson&rsquo;s disease.&nbsp; Tue, 21 Mar 17 20:31:56 +0000 American Diabetes Association Alert Day Coming Up http://www.pharmacytimes.com/news/american-diabetes-association-alert-day-coming-up http://www.pharmacytimes.com/news/american-diabetes-association-alert-day-coming-up An estimated 86 million Americans have prediabetes, and 90% of them don&#39;t know they have it. Tue, 21 Mar 17 15:17:57 +0000 Health Groups Call for FDA to Ban All Flavored Tobacco Products http://www.pharmacytimes.com/news/health-groups-call-for-fda-to-ban-all-flavored-tobacco-products http://www.pharmacytimes.com/news/health-groups-call-for-fda-to-ban-all-flavored-tobacco-products &nbsp;<br /> Several public health and antismoking groups are urging the FDA to enforce more stringent regulations on the manufacturing of tobacco products&nbsp;by banning candy and fruit-flavored e-cigarettes and cigars.&nbsp; Tue, 21 Mar 17 14:55:09 +0000 ASCO Issues Global HPV Vaccination Guidelines for Cervical Cancer Prevention http://www.pharmacytimes.com/news/asco-issues-global-hpv-vaccination-guidelines-for-cervical-cancer-prevention http://www.pharmacytimes.com/news/asco-issues-global-hpv-vaccination-guidelines-for-cervical-cancer-prevention The American Society of Clinical Oncology (ASCO) released a clinical practice guideline on human papillomavirus (HPV) vaccination for the primary prevention of cervical cancer.&nbsp; Mon, 20 Mar 17 14:34:15 +0000 CDC: Long-Acting Opioids, Tramadol Most Likely to be Chronically Used http://www.pharmacytimes.com/news/cdc-longacting-opioids-tramadol-most-likely-to-be-chronically-used http://www.pharmacytimes.com/news/cdc-longacting-opioids-tramadol-most-likely-to-be-chronically-used Patients who take long-acting opioids are more likely to experience chronic opioid use, a report published in the CDC&rsquo;s <em>Morbidity and Mortality Weekly Report</em> has determined.&nbsp; Fri, 17 Mar 17 17:39:34 +0000 White Coats on Instagram: What Does Pharmacy Look Like? http://www.pharmacytimes.com/news/white-coats-on-instagram-what-does-pharmacy-look-like http://www.pharmacytimes.com/news/white-coats-on-instagram-what-does-pharmacy-look-like A new study published in the <em>Journal of the American Pharmacists Association</em> analyzed the use of the &ldquo;#pharmacist&rdquo; tag on Instagram.&nbsp; Fri, 17 Mar 17 14:26:01 +0000 Pharmacy Times and Parata Systems Host the 2017 Next-Generation Pharmacist Awards Gala http://www.pharmacytimes.com/news/pharmacy-times-and-parata-systems-host-the-2017-nextgeneration-pharmacist-awards-gala http://www.pharmacytimes.com/news/pharmacy-times-and-parata-systems-host-the-2017-nextgeneration-pharmacist-awards-gala <em>Award Finalists and Attendees to Enjoy Entertainment by Craig Karges at the San Diego Zoo</em> Thu, 16 Mar 17 14:05:02 +0000 Ebola Vaccines Yield Persistent Protection in Year-Long Trial http://www.pharmacytimes.com/product-news/ebola-vaccines-yield-persistent-protection-in-yearlong-trial http://www.pharmacytimes.com/product-news/ebola-vaccines-yield-persistent-protection-in-yearlong-trial &nbsp;<br /> An investigational Ebola vaccine showed promising results in an early-stage study, in which an induced immune response persisted in adult participants for nearly 1 year after receiving the vaccination. Thu, 16 Mar 17 11:00:00 +0000 FDA Issues Safety Warning for IBS Drug http://www.pharmacytimes.com/product-news/fda-issues-safety-warning-for-ibs-drug http://www.pharmacytimes.com/product-news/fda-issues-safety-warning-for-ibs-drug The FDA has issued a warning regarding the drug Viberzi (eluxadoline), which is used to treat irritable bowel syndrome with diarrhea (IBS-D).&nbsp; Thu, 16 Mar 17 00:00:00 +0000 Talking to Senior Patients about NSAIDs: Change Is Likely http://www.pharmacytimes.com/news/talking-to-senior-patients-about-nsaids-change-is-likely http://www.pharmacytimes.com/news/talking-to-senior-patients-about-nsaids-change-is-likely NSAIDs are included in the Beers criteria list as potentially inappropriate for older patients.&nbsp; Wed, 15 Mar 17 17:22:47 +0000 FDA Approves Keytruda for Treatment of Hodgkin Lymphoma http://www.pharmacytimes.com/product-news/fda-approves-keytruda-for-treatment-of-hodgkin-lymphoma http://www.pharmacytimes.com/product-news/fda-approves-keytruda-for-treatment-of-hodgkin-lymphoma Merck has announced the FDA&rsquo;s approval of Keytruda&rsquo;s indication for treatment in classical Hodgkin lymphoma (cHL) patients.&nbsp; Wed, 15 Mar 17 14:21:18 +0000 Three Dietary Supplement Manufacturers Ordered to Halt Operations http://www.pharmacytimes.com/news/three-dietary-supplement-manufacturers-ordered-to-halt-operations http://www.pharmacytimes.com/news/three-dietary-supplement-manufacturers-ordered-to-halt-operations Officials with the FDA noted that in past inspections, dating back as far as 2012, they have noticed the&nbsp;dietary supplement products were misbranded because they were being marketed with drug claims despite not being approved for any use. Tue, 14 Mar 17 18:50:22 +0000 FDA Approves First-Line Combo Treatment for HR+/HER2- Metastatic Breast Cancer http://www.pharmacytimes.com/product-news/fda-approves-firstline-combo-treatment-for-hrher2-metastatic-breast-cancer http://www.pharmacytimes.com/product-news/fda-approves-firstline-combo-treatment-for-hrher2-metastatic-breast-cancer &nbsp;<br /> The FDA has approved Novartis&rsquo; Kisqali (ribociclib), in combination with an aromatase inhibitor as initial endocrine-based therapy treatment, for the treatment of breast cancer.&nbsp; Tue, 14 Mar 17 12:00:00 +0000 Senate Confirms Seema Verma as CMS Administrator http://www.pharmacytimes.com/news/senate-green-lights-seema-verma-as-cms-administrator http://www.pharmacytimes.com/news/senate-green-lights-seema-verma-as-cms-administrator Several health care organizations applauded the pick.&nbsp; Mon, 13 Mar 17 23:38:53 +0000 Study: Parental Concerns Influence Flu Vaccine Uptake in Children http://www.pharmacytimes.com/news/study-parental-concerns-influence-flu-vaccine-uptake-in-children http://www.pharmacytimes.com/news/study-parental-concerns-influence-flu-vaccine-uptake-in-children A recent study investigated parental attitudes toward their child receiving a flu vaccine and its negative influence on vaccination rates.&nbsp; Mon, 13 Mar 17 12:00:00 +0000 President Expected to Pick Scott Gottlieb to Head FDA http://www.pharmacytimes.com/news/president-expected-to-pick-scott-gottlieb-to-head-fda http://www.pharmacytimes.com/news/president-expected-to-pick-scott-gottlieb-to-head-fda Dr Gottlieb,&nbsp;who has written in various newspapers and other media about the need to expedite drug approvals, falls in line&nbsp;with President Trump&rsquo;s criticism of the current FDA regulatory process.&nbsp; Sat, 11 Mar 17 13:34:32 +0000